1. Phase II study of interferon alpha-2a and decarbazine in metastatic melanoma;Bajetta;Proceedings of the American Society of Clinical Oncology,1989
2. Phase I trial of a combination of R24 mouse monoclonal antibody and recombinant interleukin-2 in patients with melanoma;Bajorin;Proceedings of the American Society of Clinical Oncology,1987
3. A multifactorial analysis of melanoma: prognostic histopatholog-ical features comparing Clark's and Breolin's staging methods;Balch;Ann Surg,1978
4. Changes in the immunogenetic relationship of the B-16 melanoma to the C57B1/6 mouse;Bartlett;Bulletin Tulane University Medical Faculty,1967
5. In search of cancer immunotherapy: Illusions and realities;Benjamin;Prog Clin Cancer,1982